Rely on the most comprehensive, up-to-date legal content designed and curated by lawyers for lawyers
Work faster and smarter to improve your drafting productivity without increasing risk
Accelerate the creation and use of high quality and trusted legal documents and forms
Streamline how you manage your legal business with proven tools and processes
Manage risk and compliance in your organisation to reduce your risk profile
Stay up to date and informed with insights from our trusted experts, news and information sources
Access the best content in the industry, effortlessly — confident that your news is trustworthy and up to date.
Find up-to-date guidance on points of law and then easily pull up sources to support your advice with Lexis PSL
With over 30 practice areas, we have all bases covered. Find out how we can help
Our trusted tax intelligence solutions, highly-regarded exam training and education materials help guide and tutor Tax professionals
Regulatory, business information and analytics solutions that help professionals make better decisions
A leading provider of software platforms for professional services firms
In-depth analysis, commentary and practical information to help you protect your business
LexisNexis Blogs shed light on topics affecting the legal profession and the issues you're facing
Legal professionals trust us to help navigate change. Find out how we help ensure they exceed expectations
Lex Chat is a LexisNexis current affairs podcast sharing insights on topics for the legal profession
Discuss the latest legal developments, ask questions, and share best practice with other LexisPSL subscribers
Next in our sector-focused series - Life Sciences. We have spoken with our in-house PSLs to outline the key legal trends to watch in Life Sciences as 2019 draws to a close.
This article focuses on the following key trends: the shake up of regulation in medical devices, the new clinical trials regulation - and expected developments for 2020 - personalised medicine and big data, and cannabis based medicine.
Look out for similar 'Trends to Watch' articles from the series, focusing on different industry sectors and practice areas.
The regulation of medical devices has been overhauled and two new EU regulations, Regulation (EU) 2017/745 (the Medical Devices Regulation, MDR) and Regulation (EU) 2017/746, (the In Vitro Diagnostic Medical Device Regulation, IVDR) will apply from 26 May 2020 and 26 May 2022 respectively.
The reform was prompted by safety concerns relating to a number of devices, including some metal-on-metal hip implants and PIP breast implants, which highlighted gaps in the existing regime, as well as by recognition that the existing 20-year old regime was no longer fit for purpose given the significant technological advances in medical devices during that time. Such incidents also shed light on inconsistencies in the assessment methods of different certification bodies (known as Notified Bodies) and the need for more rigorous controls and monitoring of Notified Bodies by Member States, as well as the involvement of independent experts in the assessment of certain high risk devices. The new regulations therefore aim to improve the quality, safety and reliability of medical devices, strengthen transparency for consumers and enhance vigilance and market surveillance.
The new MDR and IVDR introduce significant changes to the medical device regulatory framework including extending the range of products that are subject to device regulation. This means that there will be many producers of previously unregulated products (eg, app developers and producers of aesthetic devices such as coloured contact lenses that do not correct vision) who are for the
Access this article and thousands of others like it free by subscribing to our blog.
Read full article
Already a subscriber? Login
Amy leads the content marketing strategy for LexisNexis UK, writing thought leadership and product content for marketing campaigns, insight reports and legal industry magazines. She is an established writer and researcher, having contributed in national publications, such as City A.M. and Financial IT. She is also one of the writers and digital editors of LexisNexis' insights blogs, the Future of Law and the In-house blog.
0330 161 1234